Lumexa Imaging Quarterly Cash Flow Statement
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
10.54+0.21 (+2.03%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lumexa Imaging free cash flow
In the quarter ended Jun 30, 2026, Lumexa Imaging generated $32.8 million of operating cash flow and spent $9.7 million on capital expenditures. That left free cash flow of $23.1 million, a free-cash-flow margin of 8.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Lumexa Imaging cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | 2.75M | 1.72M | -7.23M | -7.69M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 10.08M | 9.92M | 9.28M | 9.05M |
| Stock-Based Compensation | 12.74M | 12.27M | 8.35M | 6.37M |
| Change in Working Capital | -14.62M | -12.60M | -2.44M | -7.51M |
| Operating Cash Flow | 32.80M | 2.93M | 2.07M | -13.96M |
| Capital Expenditures | -9.67M | -5.31M | -4.60M | -1.00M |
| Investing Cash Flow | -13.64M | -5.27M | -4.17M | -720.00K |
| Debt Issued | 8.41M | 1.12M | 0 | 496.00K |
| Debt Repaid | -5.17M | -3.23M | -3.93M | -3.89M |
| Financing Cash Flow | -685.00K | -5.26M | -462.00K | -4.15M |
| Net Change in Cash | 18.48M | -7.60M | -2.56M | -18.83M |
| Free Cash Flow | 23.13M | -2.38M | -2.53M | -14.96M |
This table shows 4 quarterly periods of Lumexa Imaging's cash flow statement, from Q2 2026 back to Q? 2025, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LMRI's reporting calendar. What is a cash flow statement?